EXPERT-C: A randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined, high-risk rectal cancer

Autoria(s): Dewdney, A.; Capdevila, J.; Glimelius, B.; Cervantes, A.; Tait, D.M.; Brown, G.; Wotherspoon, A.; de Castro, D.G.; Chua, Y.J.; Wong, R.; Barbachano, Y.; Oates, J.R.; Chau, I.; Cunningham, D.
Data(s)

20/05/2011
Identificador

http://pure.qub.ac.uk/portal/en/publications/expertc-a-randomized-phase-ii-european-multicenter-trial-of-neoadjuvant-capecitabine-plus-oxaliplatin-chemotherapy-capox-and-chemoradiation-crt-with-or-without-cetuximab-followed-by-total-mesorectal-excision-tme-in-patients-with-mridefined-highrisk-rectal-cancer(023e9bdb-5697-4e3d-a352-a0822ee4e133).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Dewdney , A , Capdevila , J , Glimelius , B , Cervantes , A , Tait , D M , Brown , G , Wotherspoon , A , de Castro , D G , Chua , Y J , Wong , R , Barbachano , Y , Oates , J R , Chau , I & Cunningham , D 2011 , ' EXPERT-C: A randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined, high-risk rectal cancer ' Journal of Clinical Oncology , vol 29 , no. 15 .
Tipo

article
Acesso ao item digital